ID   OvBH-1
AC   CVCL_UY59
DR   Wikidata; Q98128403
RX   CelloPub=CLPUB00470;
RX   PubMed=11062710;
RX   PubMed=12359050;
RX   PubMed=16364757;
RX   PubMed=26925792;
CC   Population: Caucasian; Polish.
CC   Characteristics: Shows temperature-sensitive growth characteristics. Grows well at 37 Celsius and stop growing when shifted to 31 Celsius (PubMed=12359050).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous; Note=2 out of 3 copies (PubMed=16364757).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
RX   CelloPub=CLPUB00470;
RA   Bar J.K., Harlozinska-Szmyrka A.U., Wyrodek E., Kartarius S., Montenarh M.,
RA   Rodriguez-Parkitna J.M., Kochman M., Ozyhar A.;
RT   "A characterization of the temperature-sensitivity of an ovarian
RT   carcinoma cell line (OvBH-1), independent of p53 status.";
RL   Cell. Mol. Biol. Lett. 7 Suppl. 1:80-80(2002).
//
RX   PubMed=11062710;
RA   Bar J.K., Harlozinska-Szmyrka A.U.;
RT   "Morphological and phenotypic characterization of a new established
RT   ovarian carcinoma cell line (OvBH-1).";
RL   Anticancer Res. 20:2975-2980(2000).
//
RX   PubMed=12359050; DOI=10.1111/j.1349-7006.2002.tb02473.x; PMCID=PMC5927136;
RA   Bar J.K., Harlozinska-Szmyrka A.U., Kartarius S., Montenarh M., Wyrodek E.,
RA   Rodriguez-Parkitna J.M., Kochman M., Ozyhar A.;
RT   "Temperature-sensitive ovarian carcinoma cell line (OvBH-1).";
RL   Jpn. J. Cancer Res. 93:976-985(2002).
//
RX   PubMed=16364757; DOI=10.1016/j.cancergencyto.2005.04.011;
RA   Schlade-Bartusiak K., Sasiadek M.M., Bar J.K., Urbschat S., Blin N.,
RA   Montenarh M., Harlozinska-Szmyrka A.U.;
RT   "Cytogenetic and molecular cytogenetic characterization of the stable
RT   ovarian carcinoma cell line (OvBH-1).";
RL   Cancer Genet. Cytogenet. 164:10-15(2006).
//
RX   PubMed=26925792; DOI=10.4149/315_150930N510;
RA   Saczko J., Pilat J., Choromanska A., Rembialkowska N., Bar J.K.,
RA   Deszcz I., Zalewski J., Kulbacka J.;
RT   "The effectiveness of chemotherapy and electrochemotherapy on ovarian
RT   cell lines in vitro.";
RL   Neoplasma 63:450-455(2016).
//